FINANCIAL TRUST COMPANY INC ACCT. For the Period I/1/13 to 1/31/13 Trade Date Type Quantity Per Unit Amount Proceeds Tax Cost Realized Est. settle Date Selection Method Description Gain/Loss Pending Sales, Maturities, Redemptions 1/31 Sale VANGUARD NATURAL RESOURCES LLC (ID: 92205F-10-6) 25 (3,500.000) 27.75 96,982.82 (97,475.00) (492.18) S 1/31 Sale KERYX BIOPHARMACEUTICALS INC (ID: 492515-10-1) 25 (1,500.000) 9.50 14,189.68 (12,735.00) 1,454.68 S Total Pending Sales. Maturities. Redemptions $1.130A14.62 (61,130,710.00) (0296.3S) S Trade Date Quantity Per Unit Est. Settle Date Type Description Amount Market Cost Pending Securities Purchased 129 Purchase JPMORGAN CHASE & CO PFD 5.450% (ID: 46637G-12-4) 25 60,000.000 25.00 (1,500,000.00) 1/29 Purchase PIEDMONT NATURAL GAS CO INC (ID: 720186-10-5) 2/4 6,500.000 32.00 (208,000.00) 1/31 Purchase KERYX BIOPHARMACEUTICALS INC (ID: 492515-10-1) 25 1,500.000 8.49 (12,735.00) 1/31 Purchase VANGUARD NATURAL RESOURCES LLC (ID: 92205E-104q 2/5 3,500.000 27.85 (97,475.00) 1/31 Purchase ZOETIS INC (ID: 98978V-10-3) 25.000.000 26.00 (650.000.00) Total Pending Securities Purchased ($2,468,210.00) J.P Morgan Account Page 29 of 38 Consolidated Statement Page 32 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00016794 SDNY_GM_00285992 EFTA01493873